An investigation employing a rat model of CKD revealed that exogenous butyrate supplementation, a short-chain fatty acid, significantly decreased the expression levels of various critical proteins linked to NLRP3 inflammasome-mediated pyroptosis, such as NLRP3, IL-1β, caspase-1, and GSDMD. Here, IL1B is linked to chronic kidney disease.